Neurol. praxi. 2010;11(4):261-264

Headache and Multiple Sclerosis

MUDr.Soňa Feketová
1. neurologická klinika FNsP a LF UK Bratislava

Headache is not generally considered as a symptom of multiple sclerosis (MS). Several studies, however, have confirmed that headache

is more common in MS patients when compared to control groups or general population. Its occurrence is reported in 4 % to 61.8 %,

depending on individual studies. Headache may be the first sign of MS or may be manifested in the course of the disease. The most

common type of headache in MS patients is migraine without aura and tension-type headache; cluster headache is less frequent. Less

well-recognized but highly characteristic is intense headache in the nape of the neck associated with acute demyelination affecting

fossa posterior structures. In MRI scans, headache may be associated with massive occurrence of large supratentorial inflammation

lesions or lesions located in the pons area. Headache is also present as part of interferon treatment, and with simultaneously occurring

depression. Since MS patients are more susceptible to headaches, preventive treatment aimed at alleviating distress and improving the

quality of life is recommended.

Keywords: headache, multiple sclerosis, migraine, trigeminal neuralgia, demyelinating lesion, MRI, interferon treatment

Published: October 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Feketová S. Headache and Multiple Sclerosis. Neurol. praxi. 2010;11(4):261-264.
Download citation

References

  1. Abb L, Schaltebrand G. Statistische Untersuchungen zum Problem der multiplen Sklerose. II. Mitteilung das Krankheitsbild der multiplen Sklerose. Deutsch Z Nervenheilkd 1956; 174: 199-218. Go to original source...
  2. Compston A, McDonald I. The symptoms and signs of multiple sclerosis. In: Compston A, Confavreux Ch, Lassmann H, McDonald I, Miller D, Noseworthy J, Smith K, Wekerle H. McAlpine's Multiple Sclerosis. Fourth Edition. London: Elsevier Inc. 2006: 287-346. Go to original source...
  3. D'Amico D, La Mantia L, Rigamonti A, Usai S, Mascoli N, Milanese C, Bussone G. Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia 2004; 24: 980-984. Go to original source... Go to PubMed...
  4. De Simone R, Marano E, Brescia Morra E, Ranieri A, Ripa P, Esposito M, Vacca G, Bonavita V. A clinical comparison of trigeminal neuralgia pain in patients with and without underlying multiple sclerosis. Neurological Sciences 2005; 26(Suppl. 2): s150-s15. Go to original source... Go to PubMed...
  5. Freedman MS, Gray TA. Vascular headache: a presenting symptom of multiple sclerosis. Canadian Journal of Neurological Sciences 1989; 16: 63-66. Go to original source... Go to PubMed...
  6. Gee JR, Chang J, Dublin AB, Vijayan N. The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis. Headache 2005; 45: 670-677. Go to original source... Go to PubMed...
  7. Gold R, Rieckmann P, Chang P, Abdalla J, and PRISMS StudyGroup. The long-term safety and tolerability of high-dose interferon beta-1a in relapsing-remitting multiple sclerosis: 4-year data from the PRISMS study. European Journal of Neurology 2005; 12: 649-656. Go to original source... Go to PubMed...
  8. Headache Classification Subcommittee of the International Headache Society. International Classification of Headache Disorders, 2nd Ed. Cephalalgia 2004; (Suppl. 1): 9-160.
  9. Khromov A, Segal M, Nissinoff J, Fast A. Migraines linked to interferon-? treatment of multiple sclerosis. American Journal of Physical Medicine & Rehabilitation 2005; 84: 644-647. Go to original source... Go to PubMed...
  10. Kurtzke JF, Beebe GW, Nagler B, Auth TL, Kurland LT, Nefzger MD. Studies on natural history of multiple sclerosis. Acta Neurologica Scandinavica 1968; 44: 467-494. Go to original source... Go to PubMed...
  11. La Mantia L. Headache and multiple sclerosis: clinical and therapeutic correlations. Neurological Sciences 2009; 30(Suppl. 1): S23-S26. Go to original source... Go to PubMed...
  12. La Mantia L, D'Amico D, Rigamonti A, Mascoli N, Bussone G, Milanese C. Interferon treatment may trigger primary headaches in multiple sclerosis patients. Multiple Sclerosis 2006; 12: 476-480. Go to original source... Go to PubMed...
  13. Martinelli Boneschi F, Colombo B, Annovazzi P, Martinelli V, Bernasconi L, Solaro C, Comi G. Lifetime and actual prevalence of pain and headache in multiple sclerosis. Multiple Sclerosis 2008; 14: 514-521. Go to original source... Go to PubMed...
  14. Nicoletti A, Patti F, Lo Fermo S, Liberto A, Castiglione A, Laisa P, Garifoli A, La Naia F, Maimone D, Sorbello V, Contrafatto D, Zappia M. Headache and multiple sclerosis: a population-based case-control study in Catania, Sicily. Cephalalgia 2008; 28: 1163-1169. Go to original source... Go to PubMed...
  15. Pöllmann W, Erasmus LP, Feneberg W, et al. Interferon beta but not glatiramer acetate therapy aggravates headaches in MS. Neurology 2002; 59: 636-639. Go to original source... Go to PubMed...
  16. Putzki N, Pfriem A, Limmroth V, Yaldizli O, Tettenborn B, Diener HC, Katsarava Z. Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. European Journal of Neurology 2009; 16: 262-267. Go to original source... Go to PubMed...
  17. Rolak LA, Brown S. Headaches and multiple sclerosis: a clinical study and review of the literature. Journal of Neurology 1990; 237: 300-302. Go to original source... Go to PubMed...
  18. Tortorella P, Rocca Maria A, Colombo B, Annovazzi P, Comi G, Filippi M. Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis. Journal of Neurological Sciences 2006; 244: 137-141. Go to original source... Go to PubMed...
  19. Vacca G, Marano E, Brescia Morra V, Lanzillo R, de Vito M, Parente E, Orefice G. Multiple sclerosis and headache comorbidity. A case-control study. Neurological Sciences 2007; 28: 133-135. Go to original source... Go to PubMed...
  20. Villani V, Prosperini L, Ciuffoli A, Pizzolato R, Salvetti M, Pozzilli C, Sette G. Primary headache and multiple sclerosis: preliminary results of a prospective study. Neurological Sciences 2008; 29: S146-S148. Go to original source... Go to PubMed...
  21. Watkins MS, Espir M. Migraine and multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 1969; 32: 35-37. Go to original source... Go to PubMed...
  22. Waxman SG. Acquired channelopathies in nerve injury and MS. Neurology 2001; 56: 1621-1627. Go to original source... Go to PubMed...
  23. Yetimalar Y, Secil Y, Inceoglu AK, Eren S, Basoglu M. Unusual primary manifestations of multiple sclerosis. New Zealand Medical Journal 2008; 121: 47-59.
  24. Zorzon M, Zivadinov R, Nasuelli D, Dolfini P, Bosco A, Bratina A, Tommasi MA, Locatelli L, Cazzato G. Risk factors of multiple sclerosis: A case-control study. Neurological Sciences 2003; 24: 242-247. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.